Roman Butler Fullerton & Co »

Corcept Therapeutics Incorporated shares owned by Roman Butler Fullerton & Co

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Roman Butler Fullerton & Co from 13F filings

Historical chart of Roman Butler Fullerton & Co investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Roman Butler Fullerton & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Roman Butler Fullerton & Co

Quarter filed Position value Share count Share price at filing
2025-03-31 $233k 3.4k 69.59
2024-12-31 $1.6M 27k 60.30
2024-09-30 $261k 5.6k 46.84
2024-06-30 $491k 16k 30.62
2024-03-31 $207k 9.3k 22.30

More positions owned by Roman Butler Fullerton & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Mastercard Incorporated Cl A (MA)
Vanguard Specialized Funds Div App Etf (VIG)
Wal-Mart Stores (WMT)
Vanguard Index Fds Growth Etf (VUG)
Eli Lilly & Co. (LLY)
Cigna Corp (CI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Proshares Tr S&p 500 Dv Arist (NOBL)

View all positions for Roman Butler Fullerton & Co

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Renaissance Technologies
Parallel Advisors
State Street Corporation
FMR
Geode Capital Management
Dimensional Fund Advisors
Morgan Stanley
AQR Capital Management
ClearBridge Advisors
Charles Schwab Investment Management
TD Asset Management
Jpmorgan Chase & Co

View all funds holding Corcept Therapeutics Incorporated